ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2013 | $235,000 | – | 12,762 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,331,100 | $23,281,000 | 8.28% |
DAFNA Capital Management LLC | 191,215 | $3,344,000 | 4.89% |
Redmile Group, LLC | 1,277,109 | $22,337,000 | 3.94% |
BB BIOTECH AG | 3,115,371 | $54,488,000 | 3.92% |
SECTORAL ASSET MANAGEMENT INC | 5,292,682 | $92,569,000 | 2.74% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 565,956 | $9,899,000 | 1.76% |
OAK RIDGE INVESTMENTS LLC | 2,645,781 | $46,275,000 | 1.45% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,104 | $22,127,000 | 1.04% |
Tekla Capital Management LLC | 412,965 | $7,223,000 | 0.98% |
Private Capital Advisors, Inc. | 127,600 | $2,232,000 | 0.83% |